WO2020040236A1 - ヒト免疫不全ウイルスの感染予防のための組成物 - Google Patents
ヒト免疫不全ウイルスの感染予防のための組成物 Download PDFInfo
- Publication number
- WO2020040236A1 WO2020040236A1 PCT/JP2019/032736 JP2019032736W WO2020040236A1 WO 2020040236 A1 WO2020040236 A1 WO 2020040236A1 JP 2019032736 W JP2019032736 W JP 2019032736W WO 2020040236 A1 WO2020040236 A1 WO 2020040236A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- extract
- composition according
- extraction
- hiv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Definitions
- extracts of bitterweeds include hepatitis C virus (Hepatitis C Virus), bovine viral diarrhea virus (Bovine Virus Viral Diarrhea Virus), swine fever virus (Classical Swine Fever Virus), yellow fever virus (Yellow Fever Virus), and yellow fever virus. It acts as an anti-diffusion agent against flaviviridae viruses including Dengue virus (Patent Document 4).
- the extract is extracted from Artemisia serrata by an extraction medium containing alcohol.
- the alcohol in the extraction medium is greater than 57.5% by volume. The remainder of the extraction medium contains water.
- the alcohol in the extraction medium is 60, 70, 80, 90, 100% by volume.
- the extraction medium contains at least one of a monohydric alcohol and a dihydric alcohol as a main component.
- the extraction medium contains 98% or more ethanol by volume.
- the extraction medium is 100% 1,3-butylene glycol.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
ヒト免疫不全ウイルスの人体への感染予防のための組成物。
<2> 前記抽出物は57.5体積%を超えるアルコールを含有する抽出媒によって抽出されたものである、
<1>に記載の組成物。
<3> 前記抽出媒は一価アルコール及び二価アルコールの少なくともいずれかを主成分とする、
<2>に記載の組成物。
<4> 前記抽出媒は98体積%以上のエタノールを含有し、
残部は水を含有し、
抽出は蒸留により行われる、
<2>に記載の組成物。
<5> 前記抽出媒は100%の1,3-ブチレングリコールであり、
抽出は浸出により行われる、
<2>に記載の組成物。
<6> 水性溶液、ゲル、ゾル、クリーム及び座薬からなる群から選ばれるマイクロバイサイドである、
<1>~<5>のいずれかに記載の組成物。
<7> 皮膚又は粘膜に適用するための、
<6>に記載の組成物。
<8> ヒトのペニス又は膣内若しくは外陰部に適用するための、
<6>に記載の組成物。
<9> <1>~<5>のいずれかに記載の組成物を有し、身体の表面に適用される器具。
<10> <1>~<5>のいずれかに記載の組成物を塗布したコンドーム又はデンタルダム。
<例1>
<例2>
<例3>
Claims (10)
- ニガヨモギ(Artemisia absinthium)の抽出物を含有する組成物であって
ヒト免疫不全ウイルスの人体への感染予防のための組成物。 - 前記抽出物は57.5体積%を超えるアルコールを含有する抽出媒によって抽出されたものである、
請求項1に記載の組成物。 - 前記抽出媒は一価アルコール及び二価アルコールの少なくともいずれかを主成分とする、
請求項2に記載の組成物。 - 前記抽出媒は98体積%以上のエタノールを含有し、
残部は水を含有し、
抽出は直接蒸留により行われる、
請求項2に記載の組成物。 - 前記抽出媒は100%の1,3-ブチレングリコールであり、
抽出は浸出により行われる、
請求項2に記載の組成物。 - 水性溶液、ゲル、ゾル、クリーム及び座薬からなる群から選ばれるマイクロバイサイドである、
請求項1~5のいずれかに記載の組成物。 - 皮膚又は粘膜に適用するための、
請求項6に記載の組成物。 - ヒトのペニス又は膣内若しくは外陰部に適用するための、
請求項6に記載の組成物。 - 請求項1~5のいずれかに記載の組成物を有し、身体の表面に適用される器具。
- 請求項1~5のいずれかに記載の組成物を塗布したコンドーム又はデンタルダム。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020507125A JP6761559B2 (ja) | 2018-08-23 | 2019-08-22 | ヒト免疫不全ウイルスの感染予防のための組成物 |
SG11202101660PA SG11202101660PA (en) | 2018-08-23 | 2019-08-22 | Composition for preventing infection with human immunodeficiency virus |
EP19852579.2A EP3841893A4 (en) | 2018-08-23 | 2019-08-22 | COMPOSITION FOR PREVENTING TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS |
CA3109348A CA3109348C (en) | 2018-08-23 | 2019-08-22 | A composition comprising an extract of artemisia absinthium for preventing infection with human immunodeficiency virus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018168312 | 2018-08-23 | ||
JP2018-168312 | 2018-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020040236A1 true WO2020040236A1 (ja) | 2020-02-27 |
Family
ID=69591899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/032736 WO2020040236A1 (ja) | 2018-08-23 | 2019-08-22 | ヒト免疫不全ウイルスの感染予防のための組成物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3841893A4 (ja) |
JP (1) | JP6761559B2 (ja) |
CA (1) | CA3109348C (ja) |
SG (1) | SG11202101660PA (ja) |
WO (1) | WO2020040236A1 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013010728A (ja) | 2011-06-27 | 2013-01-17 | Takao Nakamura | ニガヨモギより得られた防腐・抗菌機能を有するエキス剤 |
JP2013010729A (ja) | 2011-06-27 | 2013-01-17 | Takao Nakamura | ニガヨモギ抽出液配合の女性用陰部不快臭防止剤 |
WO2015155903A1 (ja) * | 2014-04-07 | 2015-10-15 | 孝男 中村 | ニガヨモギから得られたウイルス拡散防止剤 |
JP2018123110A (ja) | 2017-02-03 | 2018-08-09 | 国立大学法人 熊本大学 | ウイルス吸着剤、該吸着剤を含むウイルス吸着性部材およびマイクロバイサイド |
JP2018168312A (ja) | 2017-03-30 | 2018-11-01 | 株式会社日本触媒 | 水溶性重合体 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH695757A5 (de) * | 2001-09-24 | 2006-08-31 | Heinz Forster | Pharmazeutische Zusammensetzung. |
CN101669979B (zh) * | 2009-10-09 | 2012-07-11 | 新疆维吾尔自治区药物研究所 | 滨蒿提取物及其生产方法和应用 |
CN103239712A (zh) * | 2012-02-14 | 2013-08-14 | 天津市扶素生物技术有限公司 | Hiv杀微生物剂及其应用 |
-
2019
- 2019-08-22 CA CA3109348A patent/CA3109348C/en active Active
- 2019-08-22 JP JP2020507125A patent/JP6761559B2/ja active Active
- 2019-08-22 WO PCT/JP2019/032736 patent/WO2020040236A1/ja unknown
- 2019-08-22 SG SG11202101660PA patent/SG11202101660PA/en unknown
- 2019-08-22 EP EP19852579.2A patent/EP3841893A4/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013010728A (ja) | 2011-06-27 | 2013-01-17 | Takao Nakamura | ニガヨモギより得られた防腐・抗菌機能を有するエキス剤 |
JP2013010729A (ja) | 2011-06-27 | 2013-01-17 | Takao Nakamura | ニガヨモギ抽出液配合の女性用陰部不快臭防止剤 |
WO2015155903A1 (ja) * | 2014-04-07 | 2015-10-15 | 孝男 中村 | ニガヨモギから得られたウイルス拡散防止剤 |
JP2017105712A (ja) | 2014-04-07 | 2017-06-15 | 孝男 中村 | ウイルス拡散防止剤 |
JP2018123110A (ja) | 2017-02-03 | 2018-08-09 | 国立大学法人 熊本大学 | ウイルス吸着剤、該吸着剤を含むウイルス吸着性部材およびマイクロバイサイド |
JP2018168312A (ja) | 2017-03-30 | 2018-11-01 | 株式会社日本触媒 | 水溶性重合体 |
Non-Patent Citations (2)
Title |
---|
KAWATA, TAKUYA : "Screening of Egyptian folk medicinal plant extracts for anti-human immunodeficiency virus type-1 (HIV-1) activity", JOURNAL OF TRADITIONAL MEDICINES, vol. 13, 30 November 1995 (1995-11-30), pages 59 - 65, XP009526479, ISSN: 1340-6302 * |
MOHABATKAR, HASSAN ET AL.: "Effects of root, shoot, leaf and seed extracts of seven Artemisia species on HIV-1 replication and CD 4 expression", JOURNAL OF COASTAL LIFE MEDICINE, vol. 3, 2015, pages 996 - 999, XP055688188 * |
Also Published As
Publication number | Publication date |
---|---|
SG11202101660PA (en) | 2021-03-30 |
JPWO2020040236A1 (ja) | 2020-08-27 |
CA3109348C (en) | 2023-10-17 |
EP3841893A4 (en) | 2022-05-18 |
EP3841893A1 (en) | 2021-06-30 |
JP6761559B2 (ja) | 2020-09-23 |
CA3109348A1 (en) | 2020-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6027716A (en) | Synergistic herbal extracts | |
CA2974166C (en) | Microbicidal oil-in-water dispersion | |
CN108348636A (zh) | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 | |
FR2641466A1 (fr) | Composition pour la prevention du traitement medical de la parodonthopathie | |
GB2326595A (en) | A formulation useful as a herbal cream for cracked heels and palms | |
US20080145461A1 (en) | Formulation and method of making a topical pain relief composition | |
JP6761559B2 (ja) | ヒト免疫不全ウイルスの感染予防のための組成物 | |
FR2830198A1 (fr) | Compositions pharmaceutiques comprenant des huiles essentielles et leurs utilisations | |
JP6858367B2 (ja) | ウイルス吸着剤、該吸着剤を含むウイルス吸着性部材およびマイクロバイサイド | |
US11446240B2 (en) | Personal lubricants comprising lambda-carrageenan | |
US1870107A (en) | Medicated ointment composition | |
WO1990001935A1 (fr) | Utilisation d'agent actif contre les retrovirus et produits ainsi mis en ×uvre | |
US20160102067A1 (en) | Oxiran amines | |
CA1324756C (fr) | Butyl hydroxyanisoles pour le traitement des maladies a retro-virus, comme agents modificateurs a l'infectivite des retro-virus et comme produits anti-infectants | |
US11744796B2 (en) | Personal lubricants comprising lambda-carrageenan | |
CA2524092A1 (fr) | Composition et utilisation de l'iode pur dissout dans l'huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia | |
WO2023046892A1 (fr) | Solution aqueuse a base de syzygium aromaticum, procede de preparation et utilisations associees | |
US1581798A (en) | Topical remedy | |
US1609710A (en) | Composition for the treatment of skin affections | |
US20090092691A1 (en) | Formulation Based on Marigold, Aloe, and Centellae | |
CA3183518A1 (en) | Personal lubricants comprising lambda-carrageenan | |
BG3739U1 (bg) | Състав на противовъзпалителна таблетка | |
RO133478A2 (ro) | Compoziţie pe bază de argint, şi metodă de aplicare | |
JPH0369331B2 (ja) | ||
Sirisinghe et al. | Abstracts 1st International Conference on the Medicinal Uses of Honey (From Hive to Therapy): 26TH-28TH August 2006 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2020507125 Country of ref document: JP Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19852579 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 3109348 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2019852579 Country of ref document: EP Effective date: 20210323 |